# Clinical trials recruiting in South Dakota: 339 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 339 trials recruiting or not yet recruiting with a site in South Dakota, as read on November 19, 2026.

## The full list

Clinical trials recruiting in South Dakota: 339 rows for $16.95, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/south-dakota

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 339
- Recruiting or not yet: 339
- Read on: November 19, 2026

## Trials

The 25 newest of 339, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07931651 | Wancantognaka Project (The Generosity Project) | University of Michigan | Not applicable | Not yet recruiting | Lakota Adapted Crime Prevention Through Environmental Design (CPTED) Program to Reduce Interpersonal Community Violence | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931651) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| October 9, 2026 | NCT07869498 | Ocular Dysbiosis in Eyelid Disease | Sponsor not shown (see the record) | Observational | Recruiting | Anterior Blepharitis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869498) |
| October 9, 2026 | NCT07867080 | A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME). | 4D Molecular Therapeutics | Phase 3 | Recruiting | Diabetic Macular Edema (DME) | 514 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867080) |
| October 8, 2026 | NCT07865858 | Lakota Family Acceptance Project Pilot RCT | University of Michigan | Not applicable | Recruiting | LGBTQ, Racial Disparities, Family Relationships, Minority Stress, Depression, Anxiety, Drug Use, Teen Dating Violence... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865858) |
| October 2, 2026 | NCT07856680 | Clinical Lid Eradication of Antifungal-Responsive FUNGUS Study | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Anterior Blepharitis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856680) |
| August 27, 2026 | NCT07790887 | A Prospective, Single-Arm Clinical Evaluation of Visual, Refractive, and Patient-Reported Outcomes Following Bilateral Implantation of the... | Vance Thompson Vision | Phase 4 | Not yet recruiting | Cataract | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07790887) |
| August 27, 2026 | NCT07790211 | BL-RX01-TFSTAB-1402 | Vance Thompson Vision | Phase 4 | Recruiting | Dry Eye | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07790211) |
| August 27, 2026 | NCT07790185 | Evaluation of Mesopic Visual Acuity and Patient Satisfaction Following Ray-Tracing-Guided LASIK | Vance Thompson Vision | Phase 4 | Recruiting | Astigmatism, Myopia | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07790185) |
| August 21, 2026 | NCT07780656 | A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very... | GlaxoSmithKline | Phase 3 | Recruiting | Pulmonary Disease, Chronic Obstructive | 624 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780656) |
| August 20, 2026 | NCT07775495 | Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure | Ecotera Health LLC | Observational | Recruiting | Healthy Adult Participants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775495) |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761117) |
| August 11, 2026 | NCT07757113 | Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolization | Sanford Health | Not applicable | Not yet recruiting | Chronic Subdural Hematoma, Stroke, Middle Meningeal Artery Embolization | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07757113) |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753993) |
| July 29, 2026 | NCT07734844 | A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO | Kodiak Sciences Inc | Phase 3 | Recruiting | Diabetic Macular Edema (DME) | 910 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734844) |
| July 20, 2026 | NCT07712796 | Empowerment Self Defense Program for Adult Native Women Survivors of Sexual Violence | University of Michigan | Not applicable | Recruiting | Depression and Quality of Life, Sexual Violence, PTSD, Suicidal Ideation, Problem Drinking | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07712796) |
| July 17, 2026 | NCT07711002 | Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy... | AstraZeneca | Phase 3 | Recruiting | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) | 1,330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711002) |
| July 2, 2026 | NCT07680790 | Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination... | Bristol-Myers Squibb | Phase 3 | Recruiting | Non-Small Cell Lung Cancer | 850 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680790) |
| June 26, 2026 | NCT07671001 | A Study of Depemokimab in Participants of 6 to 11 Years of Age | GlaxoSmithKline | Phase 3 | Recruiting | Asthma | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07671001) |
| June 25, 2026 | NCT07667803 | A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM | AstraZeneca | Phase 3 | Recruiting | Weight Management | 4,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667803) |
| June 16, 2026 | NCT07650708 | A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK | Vance Thompson Vision | Phase 4 | Recruiting | Dry Eye Syndrome (DES), Dry Eye Disease (DED) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07650708) |
| June 15, 2026 | NCT07647328 | A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer | AstraZeneca | Phase 3 | Recruiting | ER-Positive HER2-Negative Breast Cancer | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07647328) |
| June 9, 2026 | NCT07636590 | Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency | Claris Biotherapeutics, Inc. | Observational | Recruiting | Limbal Stem Cell Deficiency | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636590) |
| June 8, 2026 | NCT07633470 | A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE) | Alpha Cognition, Inc | Phase 4 | Recruiting | Alzheimer Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07633470) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Sanford USD Medical Center - Sioux Falls | Sioux Falls | 89 |
| Sanford Cancer Center Oncology Clinic | Sioux Falls | 65 |
| Avera Cancer Institute | Sioux Falls | 44 |
| Rapid City Regional Hospital | Rapid City | 22 |
| Sanford Cancer Center | Sioux Falls | 16 |
| Avera Cancer Institute - Mitchell | Mitchell | 13 |
| Sanford Health | Sioux Falls | 12 |
| Avera Cancer Institute at Yankton | Yankton | 10 |
| Avera Cancer Institute-Aberdeen | Aberdeen | 9 |
| Avera Cancer Institute at Pierre | Pierre | 9 |
| Circle Clinical Research | Sioux Falls | 8 |
| Avera Cancer Institute- Research | Sioux Falls | 7 |
| Monument Health Clinical Research | Rapid City | 7 |
| Avera Cancer Institute - Yankton | Yankton | 6 |
| Avera Cancer Institute - Aberdeen | Aberdeen | 5 |
| Avera Research Institute | Sioux Falls | 5 |
| Vance Thompson Vision | Sioux Falls | 5 |
| Avera Cancer Institute - Pierre | Pierre | 4 |
| Avera Medical Group | Sioux Falls | 4 |
| Avera Research Institute - Sioux Falls | Sioux Falls | 4 |
| Monument Health | Rapid City | 4 |
| North Central Heart | Sioux Falls | 4 |
| Health Concepts | Rapid City | 4 |
| Sanford USD Medical Center | Sioux Falls | 4 |
| Dunes Clinical Research | Dakota Dunes | 3 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 8 |
| Phase 1/2 | 10 |
| Phase 2 | 60 |
| Phase 2/3 | 13 |
| Phase 3 | 151 |
| Phase 4 | 12 |
| Not applicable | 43 |
| Observational | 42 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 23 |
| Breast Neoplasms | 20 |
| Lung Neoplasms | 15 |
| Heart Failure | 15 |
| Ovarian Neoplasms | 14 |
| Neoplasms | 14 |
| Colorectal Neoplasms | 11 |
| Endometrial Neoplasms | 11 |
| Neoplasm Metastasis | 9 |
| Prostatic Neoplasms | 9 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Cardiovascular Diseases | 8 |
| Melanoma | 8 |
| Colonic Neoplasms | 8 |
| Pancreatic Neoplasms | 8 |
| Triple Negative Breast Neoplasms | 7 |
| Pulmonary Disease, Chronic Obstructive | 7 |
| Leukemia, Myeloid, Acute | 7 |
| Fallopian Tube Neoplasms | 6 |
| Hematologic Neoplasms | 6 |
| Diabetes Mellitus, Type 2 | 5 |
| Burkitt Lymphoma | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Obesity | 5 |
| Adenocarcinoma Of Esophagus | 5 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 29 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 21 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 19 |
| Children's Oncology Group | 16 |
| Alliance for Clinical Trials in Oncology | 15 |
| NRG Oncology | 14 |
| SWOG Cancer Research Network | 13 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 10 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 8 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 6 |
| ECOG-ACRIN Cancer Research Group | 6 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 6 |
| Vance Thompson Vision | 6 |
| Sanford Health | 5 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 5 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 5 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 5 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 4 |
| University of Michigan | 4 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 4 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 3 |
| [Daiichi Sankyo](https://specstream.ai/data/clinical-trials/company/daiichi-sankyo) | 3 |
| Kodiak Sciences Inc | 3 |
| Tempus AI | 3 |
| Wake Forest University Health Sciences | 3 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in South Dakota

- [Chicken restaurants in South Dakota, United States](https://specstream.ai/data/businesses/chicken-restaurants/south-dakota-united-states)
- [Fire protection companies in South Dakota, United States](https://specstream.ai/data/businesses/fire-protection-companies/south-dakota-united-states)
- [Mental health clinics in South Dakota, United States](https://specstream.ai/data/businesses/mental-health-clinics/south-dakota-united-states)
- [Restaurants in South Dakota, United States](https://specstream.ai/data/businesses/restaurants/south-dakota-united-states)
- [Assisted living facilities in South Dakota, United States](https://specstream.ai/data/businesses/assisted-living-facilities/south-dakota-united-states)
- [Criminal defense law firms in South Dakota, United States](https://specstream.ai/data/businesses/criminal-defense-law-firms/south-dakota-united-states)
